戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  responses than Zaire Ebola virus (ZEBOV) or Marburg virus.
2 entified in Ebola virus GP1 are conserved in Marburg virus.
3 se caused by the filoviruses Ebola virus and Marburg virus.
4 osure of rhesus macaques to a lethal dose of Marburg virus.
5 ected primates respond following exposure to Marburg virus.
6 strategies against infections with Ebola and Marburg viruses.
7 for the largest outbreak ever documented for Marburg viruses.
8                                              Marburg virus, a cousin of Ebola virus, causes severe he
9 completely protect nonhuman primates against Marburg virus and 3 different species of Ebola virus.
10 t virus, Bundibugyo virus, Reston virus, and Marburg virus and differentiated between the genera Ebol
11                              The filoviruses Marburg virus and Ebola virus cause severe hemorrhagic f
12 typed with Marburg virus GP(1,2), as well as Marburg virus and Ebola virus infection in a dose-depend
13 sembled using filovirus matrix proteins from Marburg virus and Ebola virus is also sensitive to inhib
14                             The filoviruses, Marburg virus and Ebola virus, cause severe hemorrhagic
15 ope glycoproteins (GPs) from the filoviruses Marburg virus and Ebola virus.
16 re likely induced in response to exposure to Marburg virus and further suggested that the early immun
17 ndibugyo virus (BDBV), Sudan virus, and even Marburg virus and Lloviu virus, which belong to the hete
18           VP24 is only 30% identical between Marburg virus and the ebolaviruses.
19                   Filoviruses, which include Marburg viruses and Ebola viruses, are zoonotic pathogen
20 n, Tai Forest, Bundibugyo, Zaire, Sudan, and Marburg viruses and found two antibodies that showed pan
21 ae contains three genera, Ebolavirus (EBOV), Marburg virus, and Cuevavirus.
22  dengue virus, West Nile virus, Ebola virus, Marburg virus, and Zika virus.
23                  In addition, we showed that Marburg virus Angola and Ebola virus Makona-WPGC07 effic
24        The filoviruses Ebola Zaire virus and Marburg virus are believed to infect target cells throug
25 uctures and visual images of the proteins of Marburg virus are essential for the development of antiv
26  while the ebolaviruses Sudan and Reston and Marburg virus are not.
27 onstrate that the VP35s from Ebola virus and Marburg virus are the major suppressors of DC maturation
28                                    Ebola and Marburg viruses are believed to enter host cells by rece
29                                    Ebola and Marburg viruses are filoviruses: filamentous, enveloped
30             The filoviruses, Ebola virus and Marburg virus, are zoonotic pathogens that cause severe
31 re resistant to infection by Ebola virus and Marburg virus, but remain fully susceptible to a suite o
32                                              Marburg virus can cause severe disease, with up to 90% h
33                 Infection of Ebola virus and Marburg virus can cause severe illness in humans with a
34                 Infection by Ebola virus and Marburg virus can cause severe illness in humans, with a
35                                    Ebola and Marburg viruses can cause hemorrhagic fever (HF) outbrea
36                              Ebola virus and Marburg virus cause serious disease outbreaks with high
37             Filoviruses, including Ebola and Marburg viruses, cause rapidly fatal diseases in humans
38                                              Marburg virus causes a severe infection that is associat
39 To better understand the overall response to Marburg virus challenge, we undertook a transcriptomic a
40  the Ravn strain (RAVV VP40)-from a distinct Marburg virus clade-is demonstrated to also inhibit IFN
41 ganda and was confirmed to be an outbreak of Marburg virus disease (MVD).
42  of BCX4430 protects against Ebola virus and Marburg virus disease in rodent models.
43 fever, Ebola virus disease, Lassa fever, and Marburg virus disease.
44 he trafficking and subsequent release of the Marburg virus from infected cells.
45 d Sudan glycoproteins and one (MAR) encoding Marburg virus glycoprotein.
46 e, we present the 3.6 A crystal structure of Marburg virus GP in complex with a cross-reactive antibo
47 bited entry of retroviruses pseudotyped with Marburg virus GP(1,2), as well as Marburg virus and Ebol
48 tro potency of CV-N to inhibit EboZV GP- and Marburg virus GP-pseudotyped viruses (EC50 approximately
49 s highly similar to those of Ebola virus and Marburg virus GP2 despite CASV genome homology to arenav
50 ructure has been observed in Ebola virus and Marburg virus GP2, as well as other viruses that enter v
51 uring mouse adaptation of the Ravn strain of Marburg virus have impacted the budding function of the
52 filoviruses including Sudan, Bundibugyo, and Marburg viruses have caused human outbreaks with mortali
53 herapeutics are licensed to counter Ebola or Marburg viruses, highly pathogenic filoviruses that are
54 omologous protection against Ebola virus and Marburg virus in a prophylactic setting against in macaq
55 EV) demonstrated protective efficacy against Marburg virus in nonhuman primates.
56  are currently no approved interventions for Marburg virus, in part because a small-animal model that
57 ar requirements of nucleocapsid transport in Marburg virus-infected cells under biosafety level 4 con
58 nes whose disruption allowed the survival of Marburg virus-infected cells, suggesting that Rab9 is ut
59 ngs demonstrate very early host responses to Marburg virus infection and provide a rich data set for
60  were tested for evidence of acute or recent Marburg virus infection by reverse transcription-polymer
61 study, we carefully analyzed the timeline of Marburg virus infection in nonhuman primates in order to
62 We evaluated the susceptibility to Ebola and Marburg virus infection of mice that cannot respond to i
63 completely protects cynomolgus macaques from Marburg virus infection when administered as late as 48
64  significantly increased survival time after Marburg virus infection.
65 own to protect macaques from Ebola virus and Marburg virus infections, both prophylactically and post
66 showing their utility in combating Ebola and Marburg virus infections.
67  development of life-saving measures against Marburg virus infections.
68   The findings imply that reservoir hosts of Marburg virus inhabit caves, mines, or similar habitats.
69                                              Marburg virus is a genetically simple RNA virus that cau
70 aviruses is immunosuppressive, while that of Marburg virus is not.
71                       One key protein in the Marburg virus life cycle is VP40, which both assembles t
72 ve different viruses, including Ebola virus, Marburg virus, lymphocytic choriomeningitis virus (LCMV)
73                       Ebola virus (EboV) and Marburg virus (MarV) (filoviruses) are the causative age
74                              Infections with Marburg virus (MARV) and Ebola virus (EBOV) cause severe
75                                              Marburg virus (MARV) and Ebola virus (EBOV), members of
76 members of the Marburgvirus genus, including Marburg virus (MARV) and Ravn virus (RAVV), is difficult
77                                              Marburg virus (MARV) and the ebolaviruses belong to the
78                       Ebola virus (EBOV) and Marburg virus (MARV) are among the deadliest human patho
79 sms by which neutralizing antibodies inhibit Marburg virus (MARV) are not known.
80       The filoviruses Ebola virus (EBOV) and Marburg virus (MARV) are responsible for devastating hem
81                       Ebola virus (EBOV) and Marburg virus (MARV) belong to the Filoviridae family an
82                       Ebola virus (EBOV) and Marburg virus (MARV) cause rapidly progressive hemorrhag
83       Here we report rescue of a recombinant Marburg virus (MARV) expressing EGFP from an additional
84     In the seven protein-coding genes in the Marburg virus (MARV) genome, the synonymous nucleotide d
85 ll as the addition of Sudan virus (SUDV) and Marburg virus (MARV) GP containing virions.
86                                              Marburg virus (MARV) has been associated with sporadic e
87                                              Marburg virus (MARV) has caused outbreaks of filoviral h
88 n virus (SUDV), Bundibugyo virus (BDBV), and Marburg virus (MARV) have also caused sizeable human out
89 dated as an inhibitor of infectious EBOV and Marburg virus (MARV) in cell-based assays, with 50% inhi
90                                              Marburg virus (MARV) infection causes a severe and often
91                                              Marburg virus (MARV) infection causes severe morbidity a
92                         The 2005 outbreak of Marburg virus (MARV) infection in Angola was the most le
93                                              Marburg virus (MARV) infection is a lethal hemorrhagic f
94  of cynomolgus monkeys against Lake Victoria Marburg virus (MARV) infection.
95                                              Marburg virus (MARV) is a highly pathogenic filovirus th
96                                              Marburg virus (MARV) is a lipid-enveloped filamentous vi
97                                              Marburg virus (MARV) is a lipid-enveloped virus from the
98                                              Marburg virus (MARV) is an emerging zoonotic pathogen th
99 targets the viral messenger RNA that encodes Marburg virus (MARV) nucleoprotein.
100 e particles (VLPs) of Ebola virus (EBOV) and Marburg virus (MARV) produced in human 293T embryonic ki
101 2 closely related plaque-derived variants of Marburg virus (MARV) species Lake Victoria marburgvirus,
102            Phylogenetic comparisons of known Marburg virus (MARV) strains reveal 2 distinct genetic l
103  that the filoviruses Ebola virus (EBOV) and Marburg virus (MARV) suppress DC maturation in vitro Bot
104 s, we delivered an antigen-capture assay for Marburg virus (MARV) that was based on llama single-doma
105                                              Marburg virus (MARV), a close relative of Ebola virus, i
106                                              Marburg virus (MARV), a member of the Filoviridae family
107                                              Marburg virus (MARV), a member of the filovirus family,
108 iruses, consisting of Ebola virus (EBOV) and Marburg virus (MARV), are among the most lethal infectio
109 ruses, including both Ebola virus (EBOV) and Marburg virus (MARV), can infect humans and other animal
110                          Immune responses to Marburg virus (MARV), however, remain almost entirely un
111 y lethal filoviruses, Ebola virus (EBOV) and Marburg virus (MARV), in humans.
112 re highly conserved among filoviruses except Marburg virus (MARV), suggesting that MARV may not bind
113 oding the glycoprotein (GP) gene from Angola Marburg virus (MARV), were compared for their ability to
114                                              Marburg virus (MARV), which belongs to the virus family
115                          In the first study, Marburg virus (MARV)-infected NHPs were treated 15 to 30
116 hogenic and biological threat agents such as Marburg virus (MARV).
117 were inoculated subcutaneously (n = 22) with Marburg virus (MARV).
118 ette bat (ERB) is a known reservoir host for Marburg virus (MARV).
119 te bat (ERB) is a natural reservoir host for Marburg virus (MARV); however, the mechanisms by which M
120 f lethal infection with the Angola strain of Marburg virus (MARV-Ang) in rhesus macaques and tested t
121                         The Angola strain of Marburg virus (MARV/Ang) was responsible for the largest
122 ) and nucleoprotein (NP) of Ebola (EBOV) and Marburg viruses (MARV) play key roles during virion asse
123                                              Marburg viruses (MARVs) cause highly lethal infections i
124                        Recombinant Ebola and Marburg virus matrix VP40 and glycoprotein (GP) antigens
125 r hosts of highly virulent pathogens such as Marburg virus, Nipah virus, and SARS coronavirus.
126 he putative matrix protein of both Ebola and Marburg viruses, possesses a conserved proline-rich moti
127 ]R downward arrow), and one is predicted for Marburg viruses (R[R/K]KR downward arrow), although in a
128  that the VP40 protein of the Ravn strain of Marburg virus (Ravn virus [RAVV]) failed to block IFN si
129 lecular automaton able to diagnose Ebola and Marburg virus sequences.
130        A comparison with the closely related Marburg virus shows that the N-terminal region of nucleo
131 e ZEBOV and Sudan Ebolavirus and 4 different Marburg virus strains produced severe, but more slowly p
132 roup received the same dose of the VSV-based Marburg virus vaccine at both time points; another group
133 cluding the group treated with the VSV-based Marburg virus vaccine.
134                     The crystal structure of Marburg virus VP24, presented here, reveals that althoug
135 ays, including Ebola virus VP35 and VP24 and Marburg virus VP35, VP40, and VP24, on DC maturation and
136 the corresponding (84)LPLGIM(89) sequence of Marburg virus VP40 (mVP40) are critical for efficient re
137                                          The Marburg virus VP40 protein is a viral matrix protein tha
138   Here we provide the molecular structure of Marburg virus VP40, illustrate differences from VP40 of
139             The host response to aerosolized Marburg virus was evident at 1 day postexposure.
140 using in vitro affinity reagent selection on Marburg virus we rapidly established monoclonal affinity
141 an completely protect rhesus monkeys against Marburg virus when administered after exposure and can p
142  virus, Lassa virus, LCMV, rabies virus, and Marburg virus, which was substituted for the VSV glycopr

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top